A deep learning algorithm to translate and classify cardiac electrophysiology

  1. Parya Aghasafari Ph.D.
  2. Pei-Chi Yang Ph.D.
  3. Divya C Kernik Ph.D.
  4. Kazuho Sakamoto Ph.D.
  5. Yasunari Kanda Ph.D.
  6. Junko Kurokawa Ph.D
  7. Igor Vorobyov
  8. Colleen E Clancy Ph.D.  Is a corresponding author
  1. University of California Davis, United States
  2. Washington University in St. Louis, United States
  3. University of Shizuoka, Japan
  4. National Institute of Health Sciences, Japan
  5. University California Davis, United States

Abstract

The development of induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) has been a critical in vitro advance in the study of patient-specific physiology, pathophysiology and pharmacology. We designed a new deep learning multitask network approach intended to address the low throughput, high variability and immature phenotype of the iPSC-CM platform. The rationale for combining translation and classification tasks is because the most likely application of the deep learning technology we describe here is to translate iPSC-CMs following application of a perturbation. The deep learning network was trained using simulated action potential (AP) data and applied to classify cells into the drug-free and drugged categories and to predict the impact of electrophysiological perturbation across the continuum of aging from the immature iPSC-CMs to the adult ventricular myocytes. The phase of the AP extremely sensitive to perturbation due to a steep rise of the membrane resistance was found to contain the key information required for successful network multitasking. We also demonstrated successful translation of both experimental and simulated iPSC-CM AP data validating our network by prediction of experimental drug-induced effects on adult cardiomyocyte APs by the latter.

Data availability

Since we used simulated data, we have made all drugged and drug-free iPSC-CM and adult-CM AP data used for training and testing the multitask network publicly available at Clancy lab Github.(https://github.com/ClancyLabUCD/Multitask_network/tree/master/data). In addition, we have illustrated training and test dataset in Figure1 and Figure5.We have also shared the jupyter notebook for preparing clean and organized data for training the network at Clancy lab Github (https://github.com/ClancyLabUCD/Multitask_network/tree/master/jupyter).We also made experimental data used for the model validation publicly available at Clancy lab Github.(https://github.com/ClancyLabUCD/Multitask_network/blob/master/data/clean_data/experiments.csv ). Figure 7 illustrates the experimental data we used to validate the network.

Article and author information

Author details

  1. Parya Aghasafari Ph.D.

    Physiology and Membrane Biology, University of California Davis, Davis, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Pei-Chi Yang Ph.D.

    Physiology and Membrane Biology, University of California Davis, Davis, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Divya C Kernik Ph.D.

    Biomedical Engineering, Washington University in St. Louis, St. Louis, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Kazuho Sakamoto Ph.D.

    Bio-Informational Pharmacology, University of Shizuoka, Shizuoka, Japan
    Competing interests
    The authors declare that no competing interests exist.
  5. Yasunari Kanda Ph.D.

    Division of Pharmacology, National Institute of Health Sciences, Kanagawa, Japan
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2527-3526
  6. Junko Kurokawa Ph.D

    Bio-Informational Pharmacology, University of Shizuoka, Shizuoka, Japan
    Competing interests
    The authors declare that no competing interests exist.
  7. Igor Vorobyov

    University California Davis, Davis, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4767-5297
  8. Colleen E Clancy Ph.D.

    Physiology and Membrane Biology, University of California Davis, Davis, United States
    For correspondence
    ceclancy@ucdavis.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6849-4885

Funding

Common Fund (OT2OD026580)

  • Igor Vorobyov
  • Colleen E Clancy Ph.D.

Texas Advanced Computing Center Leadership Resource Allocation (MCB20010)

  • Igor Vorobyov
  • Colleen E Clancy Ph.D.

Oracle cloud for research allocation

  • Igor Vorobyov
  • Colleen E Clancy Ph.D.

Common Fund (OT2OD025308‐01S2)

  • Parya Aghasafari Ph.D.

American Heart Association (19CDA34770101)

  • Igor Vorobyov

National Heart, Lung, and Blood Institute (R01HL152681)

  • Igor Vorobyov
  • Colleen E Clancy Ph.D.

National Heart, Lung, and Blood Institute (R01HL128170)

  • Colleen E Clancy Ph.D.

National Heart, Lung, and Blood Institute (U01HL126273)

  • Colleen E Clancy Ph.D.

Department of Physiology and Membrane Biology Research Partnership Fund

  • Igor Vorobyov
  • Colleen E Clancy Ph.D.

Extreme Science and Engineering Discovery Environment (MCB170095)

  • Igor Vorobyov
  • Colleen E Clancy Ph.D.

National Center for Supercomputing Applications Blue Waters Broadening Participation Allocation

  • Igor Vorobyov
  • Colleen E Clancy Ph.D.

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2021, Aghasafari et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,025
    views
  • 294
    downloads
  • 21
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Parya Aghasafari Ph.D.
  2. Pei-Chi Yang Ph.D.
  3. Divya C Kernik Ph.D.
  4. Kazuho Sakamoto Ph.D.
  5. Yasunari Kanda Ph.D.
  6. Junko Kurokawa Ph.D
  7. Igor Vorobyov
  8. Colleen E Clancy Ph.D.
(2021)
A deep learning algorithm to translate and classify cardiac electrophysiology
eLife 10:e68335.
https://doi.org/10.7554/eLife.68335

Share this article

https://doi.org/10.7554/eLife.68335

Further reading

    1. Computational and Systems Biology
    2. Genetics and Genomics
    Jia-Ying Su, Yun-Lin Wang ... Chien-Ling Lin
    Research Article

    Untranslated regions (UTRs) contain crucial regulatory elements for RNA stability, translation and localization, so their integrity is indispensable for gene expression. Approximately 3.7% of genetic variants associated with diseases occur in UTRs, yet a comprehensive understanding of UTR variant functions remains limited due to inefficient experimental and computational assessment methods. To systematically evaluate the effects of UTR variants on RNA stability, we established a massively parallel reporter assay on 6555 UTR variants reported in human disease databases. We examined the RNA degradation patterns mediated by the UTR library in two cell lines, and then applied LASSO regression to model the influential regulators of RNA stability. We found that UA dinucleotides and UA-rich motifs are the most prominent destabilizing element. Gain of UA dinucleotide outlined mutant UTRs with reduced stability. Studies on endogenous transcripts indicate that high UA-dinucleotide ratios in UTRs promote RNA degradation. Conversely, elevated GC content and protein binding on UA dinucleotides protect high-UA RNA from degradation. Further analysis reveals polarized roles of UA-dinucleotide-binding proteins in RNA protection and degradation. Furthermore, the UA-dinucleotide ratio of both UTRs is a common characteristic of genes in innate immune response pathways, implying a coordinated stability regulation through UTRs at the transcriptomic level. We also demonstrate that stability-altering UTRs are associated with changes in biobank-based health indices, underscoring the importance of precise UTR regulation for wellness. Our study highlights the importance of RNA stability regulation through UTR primary sequences, paving the way for further exploration of their implications in gene networks and precision medicine.

    1. Computational and Systems Biology
    2. Medicine
    Hong Yang, Cheng Zhang ... Adil Mardinoglu
    Research Article

    Excessive consumption of sucrose, in the form of sugar-sweetened beverages, has been implicated in the pathogenesis of metabolic dysfunction‐associated fatty liver disease (MAFLD) and other related metabolic syndromes. The c-Jun N-terminal kinase (JNK) pathway plays a crucial role in response to dietary stressors, and it was demonstrated that the inhibition of the JNK pathway could potentially be used in the treatment of MAFLD. However, the intricate mechanisms underlying these interventions remain incompletely understood given their multifaceted effects across multiple tissues. In this study, we challenged rats with sucrose-sweetened water and investigated the potential effects of JNK inhibition by employing network analysis based on the transcriptome profiling obtained from hepatic and extrahepatic tissues, including visceral white adipose tissue, skeletal muscle, and brain. Our data demonstrate that JNK inhibition by JNK-IN-5A effectively reduces the circulating triglyceride accumulation and inflammation in rats subjected to sucrose consumption. Coexpression analysis and genome-scale metabolic modeling reveal that sucrose overconsumption primarily induces transcriptional dysfunction related to fatty acid and oxidative metabolism in the liver and adipose tissues, which are largely rectified after JNK inhibition at a clinically relevant dose. Skeletal muscle exhibited minimal transcriptional changes to sucrose overconsumption but underwent substantial metabolic adaptation following the JNK inhibition. Overall, our data provides novel insights into the molecular basis by which JNK inhibition exerts its metabolic effect in the metabolically active tissues. Furthermore, our findings underpin the critical role of extrahepatic metabolism in the development of diet-induced steatosis, offering valuable guidance for future studies focused on JNK-targeting for effective treatment of MAFLD.